scispace - formally typeset
Open AccessJournal ArticleDOI

NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing.

Reads0
Chats0
TLDR
Prager et al. show that NK cells quickly kill their first targets by releasing cytotoxic granules and only use the slower death receptor–mediated cytotoxicity for their final kill.
Abstract
NK cells eliminate virus-infected and tumor cells by releasing cytotoxic granules containing granzyme B (GrzB) or by engaging death receptors that initiate caspase cascades. The orchestrated interplay between both cell death pathways remains poorly defined. Here we simultaneously measure the activities of GrzB and caspase-8 in tumor cells upon contact with human NK cells. We observed that NK cells switch from inducing a fast GrzB-mediated cell death in their first killing events to a slow death receptor-mediated killing during subsequent tumor cell encounters. Target cell contact reduced intracellular GrzB and perforin and increased surface-CD95L in NK cells over time, showing how the switch in cytotoxicity pathways is controlled. Without perforin, NK cells were unable to perform GrzB-mediated serial killing and only killed once via death receptors. In contrast, the absence of CD95 on tumor targets did not impair GrzB-mediated serial killing. This demonstrates that GrzB and death receptor-mediated cytotoxicity are differentially regulated during NK cell serial killing.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

NK cells for cancer immunotherapy.

TL;DR: New approaches to activate NK cells, increase their proliferation in vivo and increase their capacity to recognize tumour cells are discussed.
Journal ArticleDOI

Exploring the NK cell platform for cancer immunotherapy

TL;DR: The authors discuss the variety of NK cell-based therapies that are being developed for the treatment of diverse cancers and identify future avenues for NK cell therapy research.
Journal ArticleDOI

The cancer–natural killer cell immunity cycle

TL;DR: The key role that natural killer (NK) cells play in driving an antitumour immune response throughout the progression of cancer from its initial development to its metastatic spread and eventual treatment is discussed, defined herein as the cancer–NK cell immunity cycle.
Journal ArticleDOI

Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells

TL;DR: There is an urgent need for strategies to robustly produce “off-the-shelf” CAR T and CAR NK cells, which could be used as a bridging therapy between cancer diagnosis or relapse and allogeneic transplantation.
Journal ArticleDOI

A Functional Chemiluminescent Probe for in vivo Imaging of Natural Killer Cell Activity against Tumours

TL;DR: The probe shows high selectivity for active granzyme B over other proteases and higher signal‐to‐noise ratios than commercial fluorophores and can detect NK cell activity in mouse models, being the first chemiluminescent probe for in vivo imaging of NK cellActivity in live tumours.
References
More filters
Journal ArticleDOI

CAR T cell immunotherapy for human cancer

TL;DR: Opportunities and challenges for entering mainstream oncology that presently face the CAR T field are described, with a focus on the challenges that have emerged over the past several years.
Journal ArticleDOI

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

TL;DR: Combination blockade of the PD-1/PD-L1- and CTLA-4-negative costimulatory pathways allows tumor-specific T cells that would otherwise be inactivated to continue to expand and carry out effector functions, thereby shifting the tumor microenvironment from suppressive to inflammatory.
Journal ArticleDOI

Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity

TL;DR: The perforin- and Fas-based mechanisms may account for all T cell-mediated cytotoxicity in short-term in vitro assays, and no third mechanism was detected.
Journal ArticleDOI

Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin

TL;DR: It is shown that GSDME, which was originally identified as DFNA5 (deafness, autosomal dominant 5), can switch caspase-3-mediated apoptosis induced by TNF or chemotherapy drugs to pyroptosis, suggesting that casp enzyme activation can trigger necrosis by cleaving G SDME and offer new insights into cancer chemotherapy.
Related Papers (5)